Granules India to make additional investment of $17.07 million in Granules Pharmaceutical Inc

29 Apr 2016 Evaluate

Granules India has received an approval of further investment of $17.07 million by way of debt/equity in Granules Pharmaceutical Inc., a wholly owned foreign subsidiary of the company. The board of directors at its meeting held on April 28, 2016 has approved for the same.

The board has also approved further investment of Rs 50 crore by way of debt/equity in GIL Lifescienses, a wholly owned Indian subsidiary.

Granules India produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.


Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.